ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Ozempic for weight loss could be deadly: It should not be 'given out like candy,' doctor warns

Fox News medical contributor Dr. Janette Nesheiwat is sounding off on the popular drug Ozempic, a diabetes medicine that is being used for weight loss.

Hollywood's latest weight loss trend – a diabetes medication called Ozempic – may be too good to be true.

WEGOVY, OZEMPIC: THE BARRIERS TO ACCESSING THESE WEIGHT LOSS DRUGS

During an appearance on "Mornings with Maria," Wednesday, Fox News medical contributor Dr. Janette Nesheiwat issued a pressing warning against Ozempic, cautioning users that it can cause a slew of medical side effects, including the potentially "life-threatening" ailment, intestinal obstruction.

Ozempic is an injection-based medication used once a week to treat diabetes – a disease that impacts over 100 million Americans. 

"You give this a shot to yourself once a week. And the purpose of this is to lower your blood sugar. It stimulates your pancreas to release insulin, which lowers your blood sugar, but it also sends signals to your brain that you're full. So, you have this early satiety, therefore you will lose a few pounds. But it's not without side effects," Dr. Nesheiwat stressed. 

ELON MUSK JUMPS ON NEW WEIGHT-LOSS TREND: DIABETIC MEDICATIONS

"Your blood sugar can drop too low, for example. You can have dizziness, you can have vomiting. If you have a history of thyroid cancer, it can reintroduce that cancer into your body. But why it's making headlines now is it's found to cause what's called intestinal obstruction. And that's not a common thing, but it's important that you're aware of these potential side effects. Intestinal obstruction could be life-threatening," she continued. 

Dr. Nesheiwat continued, encouraging Ozempic users to seek medical care "right away" if they suffer from the drug's dangerous side effects. 

"If you're starting to have vomiting and pain, and you don't seek medical care right away, it can cause death, ischemia of your intestines, which might require surgery. So, it's very important to know the side effects, to understand the risks versus the benefits. And that's why it's the responsibility of your doctor to let you know about these risks versus benefits. And are you a candidate? It shouldn't just be given out like candy" she explained to host Maria Bartiromo. 

Ozempic is FDA-approved to treat diabetes, however, doctors are able to "give out" the drug seemingly with no repercussions for weight loss, Dr. Nesheiwat added. 

DIABETES-RELATED WEIGHT LOSS DRUGS FACING SUPPLY ISSUES AMID VIRAL TREND

Bartiromo also pointed to the FDA's recent announcement over a shortage of the drug, posing a unique problem for diabetic Americans. 

"If you have a person who truly is a diabetic and needs this medication, that's a problem that they can't get their hands on a medicine they need. And so their blood sugars may go up, or they may be thrown off balance. And it creates a problem for those who really, truly need it."

DIABETES-RELATED WEIGHT LOSS DRUGS FACING SUPPLY ISSUES AMID VIRAL TREND

"It's so important to be cognizant of that, be cognizant of others who truly are in need of this medicine. It's a life-saving medicine. Insulin is really important to help treat diabetes. These medicines are not just, you know, to help you feel better and look better – they're to keep you alive and well," Dr. Nesheiwat explained. 

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.